Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2008-05-30Clinical Trial Update: Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients [Phase 2]
Phase 2 study of a JAK3 inhibitor for preventing acute rejection in kidney transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients [Phase 4]
Phase 4 clinical trial update evaluating a maintenance immunosuppression regimen consisting of mycophenolate mofetil, daclizumab, and cortic…
-
CLINICAL_TRIALS trial_result · 2008-04-17Clinical Trial Update: A Study to Evaluate FK778 in Kidney Transplant Patients [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating FK778 in kidney transplant patients.
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group [Phase 1]
Phase 1 trial update evaluating erythropoietin to improve renal function after kidney transplantation, compared with placebo.
-
CLINICAL_TRIALS trial_result · 2008-03-25Clinical Trial Update: Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluating rituximab plus intravenous immunoglobulin (IVIG) for desensitization in kidney transplant recip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation [Phase 2]
Phase 2 trial assessing the safety of BG9588 (anti-CD40L antibody) compared with standard treatment in kidney transplantation; the study sta…
-
FDA approval · 2007-12-20FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept to update labeling, expanding its use for prevention of organ transplant rejection in r…
-
CLINICAL_TRIALS trial_result · 2007-11-20Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS. [Phase 4]
Phase 4 trial update indicating termination of a study evaluating CellCept (mycophenolate mofetil) in kidney transplant patients switched fr…
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients [Phase 4]
Phase 4 pharmacokinetic study in kidney transplant patients evaluating the pharmacokinetics of everolimus and enteric-coated mycophenolate s…
-
CLINICAL_TRIALS research · 2007-10-19Clinical Trial Update: Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation [Phase 4]
An update on a Phase 4 trial comparing tacrolimus- and cyclosporine-based immunosuppressive regimens after kidney transplantation.
-
FDA approval · 2007-10-17FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Sirolimus from Mylan Pharmaceuticals Inc., indicating an approved change or addition to the prod…
-
FDA approval · 2007-09-21FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) from Genentech, Inc., likely resulting in an updated indica…
-
CLINICAL_TRIALS trial_result · 2007-08-20Clinical Trial Update: Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients [Phase 2]
A Phase 2 clinical trial comparing standard-dose versus reduced-dose tacrolimus in combination with sirolimus and corticosteroids for kidney…
-
CLINICAL_TRIALS trial_result · 2007-07-27Clinical Trial Update: Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus [Phase 4]
This Phase 4 clinical trial update examines the efficacy and safety of reducing cyclosporine exposure in kidney transplant recipients treate…
-
CLINICAL_TRIALS trial_result · 2007-07-03Clinical Trial Update: Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant [Phase 2]
A Phase 2 clinical trial evaluated the metabolic and renal effects of rosiglitazone in kidney transplant recipients; the study status is com…
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients [EARLY_Phase 1]
Early-phase 1 trial evaluating the immunoregulatory effects of immunoglobulin induction therapy in renal transplant recipients has completed…
-
FDA approval · 2007-05-02FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., resulting in changes to the labeling and/…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing sirolimus versus tacrolimus in African-American kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation [Phase 3]
Phase 3 trial comparing maintenance Neoral monotherapy to bitherapy in kidney transplant recipients; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-03-08Clinical Trial Update: The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus [Phase 4]
A Phase 4 clinical trial investigating how sirolimus affects the pharmacokinetics of tacrolimus in kidney transplant recipients.
-
CLINICAL_TRIALS research · 2007-03-06Clinical Trial Update: Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion [Phase 4]
This Phase 4 study evaluates reducing or stopping calcineurin inhibitors by converting kidney transplant recipients to everolimus-based immu…
-
CLINICAL_TRIALS research · 2007-02-06Clinical Trial Update: Renal Transporters After Renal Transplantation
Clinical trial update examining renal transporters in kidney transplant patients, sponsored by University Hospital Muenster; current status …
-
FDA approval · 2007-01-09FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus from Mylan Pharmaceuticals Inc., authorizing changes to the existing product appro…
-
CLINICAL_TRIALS trial_result · 2006-10-16Clinical Trial Update: Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients [NA]
A clinical trial update notes termination of a study evaluating a single-dose Thymoglobulin induction regimen in adult kidney transplant rec…
-
CLINICAL_TRIALS trial_result · 2006-05-22Clinical Trial Update: Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation [Phase 2]
This completed Phase 2 trial evaluated maintenance immunosuppression with low-dose sirolimus or cyclosporine after alemtuzumab (Campath-1) i…